PAVmed (PAVM) EPS (Basic) Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -105.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105.76% |
| Jun 30, 2025 | 37.82% |
| Mar 31, 2025 | 148.85% |
| Dec 31, 2024 | 5,066.32% |
| Jun 30, 2024 | 43.33% |
| Mar 31, 2024 | 5.76% |
| Dec 31, 2023 | 86.46% |
| Sep 30, 2023 | -720.69% |
| Jun 30, 2023 | -624.14% |
| Mar 31, 2023 | -1,290.00% |
| Dec 31, 2022 | -5,837.50% |
| Sep 30, 2022 | -93.33% |
| Jun 30, 2022 | -107.14% |
| Mar 31, 2022 | -53.85% |
| Dec 31, 2021 | -50.00% |
| Sep 30, 2021 | -36.36% |
| Jun 30, 2021 | -16.67% |
| Mar 31, 2021 | 60.61% |
| Dec 31, 2020 | 15.79% |
| Sep 30, 2020 | -10.00% |
| Jun 30, 2020 | 7.69% |
| Mar 31, 2020 | -153.85% |
| Dec 31, 2019 | 32.14% |
| Sep 30, 2019 | 16.67% |
| Jun 30, 2019 | 50.00% |
| Mar 31, 2019 | 23.53% |
| Dec 31, 2018 | -500.00% |
| Sep 30, 2018 | 68.42% |
| Jun 30, 2018 | -225.00% |
| Mar 31, 2018 | 46.88% |
| Dec 31, 2017 | 153.85% |
| Sep 30, 2017 | -171.43% |
| Jun 30, 2017 | 20.00% |
| Mar 31, 2017 | -433.33% |
| Dec 31, 2016 | -116.67% |
| Sep 30, 2016 | -180.00% |
| Jun 30, 2016 | -233.33% |
| Mar 31, 2016 | -500.00% |